Spike-specific antibody-producing B cells

Low responder status decreases spike-specific antibody-producing B cells in humans.

“Compared to matched controls, "low responders" had fewer spike-specific antibody-producing B cells after the second and third/booster doses.”

Humansafter second and third/booster doses of BNT162b2

Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination

iScience·Sep 26, 2022